FOSL1 and central nervous system cancer: Our previous findings demonstrated that reducing FOSL1 expression through siFOSL1 effectively decreased glioma cell proliferation by 30.6 to 50.2% within 24 to 96 h post-transfection in A172, U87MG cells, and PDX-L14 cells [3].